A low incidence of perineal hernia when using a biological mesh after extralevator abdominoperineal excision with or without pelvic exenteration or distal sacral resection in locally advanced rectal cancer patients - Scorecard - MDSpire
Advertisement
A low incidence of perineal hernia when using a biological mesh after extralevator abdominoperineal excision with or without pelvic exenteration or distal sacral resection in locally advanced rectal cancer patients
Clinical Scorecard: Incidence of Perineal Hernia in Locally Advanced Rectal Cancer Patients Following Extralevator Abdominoperineal Excision with Biological Mesh: A Comparative Analysis with Pelvic Exenteration and Distal Sacral Resection
At a Glance
Category
Detail
Condition
Locally advanced rectal cancer requiring extensive pelvic surgery
Key Mechanisms
Pelvic floor defects after extralevator abdominoperineal excision (ELAPE) and related surgeries; reconstruction using biological mesh and omentoplasty to reduce perineal hernia and improve wound healing
Target Population
Patients undergoing ELAPE, abdominoperineal excision (APE), pelvic exenteration (PE), or distal sacral resection (SR) for rectal cancer
Care Setting
Surgical oncology and colorectal surgery units in tertiary care centers
Key Highlights
ELAPE creates larger pelvic floor defects than conventional APE, increasing risk of perineal hernia and wound complications.
Biological mesh reconstruction (Permacol™) combined with omentoplasty shows promising reduction in perineal hernia rates (0–13%) compared to primary closure or flap reconstructions.
Lotus petal flap reconstruction can be used to fill dead space but is associated with moderate complication rates; gluteal flap reconstructions have higher perineal hernia rates than biological mesh.
Guideline-Based Recommendations
Diagnosis
Use CT imaging during follow-up to detect perineal hernia and assess wound healing.
Management
Reconstruct pelvic floor defects after ELAPE, PE, or SR using biological mesh (Permacol™) fixed to pelvic structures.
Perform omentoplasty pedicled on the right gastroepiploic artery to fill the pelvic cavity and support healing.
Consider lotus petal flap reconstruction (de-epithelialized) to fill dead space in selected cases.
Treat wound complications based on severity using conservative measures, antibiotics, vacuum-assisted closure (VAC), surgical re-intervention, or secondary flap reconstruction.
Monitoring & Follow-up
Monitor wound healing using FDA criteria: complete re-epithelialization without exudate or drainage.
Assess complications using Clavien-Dindo classification without differentiating early or late onset.
Evaluate associations of wound dehiscence with patient factors and treatment variables using appropriate statistical tests.
Risks
High wound complication rates (40–45%) with primary closure, especially after neoadjuvant radiotherapy.
Higher perineal hernia rates with gluteal flap reconstruction compared to biological mesh.
Moderate complication rates (Clavien-Dindo grade I-II in 46%) with lotus petal flap reconstruction.
Patient & Prescribing Data
35 consecutive patients undergoing pelvic floor reconstruction with biological mesh after rectal cancer surgery including ELAPE, APE, PE, or SR.
Use of Permacol™ biological mesh with omentoplasty is associated with reduced perineal hernia rates and improved wound healing compared to primary closure; lotus petal flap used selectively for dead space management.
Clinical Best Practices
Perform pelvic floor reconstruction with cross-linked porcine dermal collagen biological mesh fixed securely to pelvic sidewall and muscle remnants.
Use omentoplasty pedicled on right gastroepiploic artery to fill pelvic defects and support healing.
Apply lotus petal flap reconstruction in cases with extensive soft tissue defects to prevent fluid accumulation.
Grade complications using Clavien-Dindo classification and manage accordingly.
Use CT imaging routinely in follow-up to detect perineal hernia and monitor wound status.
Consider patient factors such as prior surgery, neoadjuvant radiotherapy, and comorbidities when planning reconstruction.